Further Evidence for Overlaps Among Chronic Pain Conditions—But No News About Causal Relationships

1. Voon P, Buxton JA, Wood E, Montaner JS, Kerr T. Dose-response relationship between functional pain interference and nonmedical analgesic use: Findings from a nationally representative Canadian survey. Can J Pain 2018;2:103–112.

2. Wasserman RA, Hassett AL, Harte SE, et al. Pressure pain sensitivity in patients with suspected opioid-induced hyperalgesia. Reg Anesth Pain Med 2015;40:687–693.

3. Samuelsen PJ, Nielsen CS, Wilsgaard T, Stubhaug A, Svendsen K, Eggen AE. Pain sensitivity and analgesic use among 10,486 adults: The Tromsø study. BMC Pharmacol Toxicol 2017;18:45.

4. Kristoffersen ES, Lundqvist C. Medication-overuse headache: Epidemiology, diagnosis and treatment. Ther Adv Drug Saf 2014;5:87–99.

5. Lyngberg AC, Rasmussen BK, Jørgensen T, Jensen R. Has the prevalence of migraine and tension-type headache changed over a 12-year period? A Danish population survey. Eur J Epidemiol 2005;20:243–249.

6. Stovner LJ, Andree C. Prevalence of headache in Europe: A review for the Eurolight project. J Headache Pain 2010;11: 289–299.

7. Lipton RB, Dodick D, Sadovsky R, et al. A self-administered screener for migraine in primary care: The ID Migraine validation study. Neurology 2003;61:375–382.

8. Cousins G, Hijazze S, Van de Laar FA, Fahey T. Diagnostic accuracy of the ID Migraine: A systematic review and meta-anal-ysis. Headache 2011;51:1140–1148.

9. Gonçalves DA, Camparis CM, Speciali JG. Temporomandibular disorders are differentially associated with headache diagnoses: A controlled study. Clin J Pain 2011;27:611–615.

10. Headache Classification Comittee of the International Head-ache Society. The International Classification of Headache Disorders, 3rd edition (ICHD-3). Cephalalgia 2018;38:1–211.

11. Internationational Classification of Orofacial Pain. Resources. https://www.ihs-headache.org/binary _data/3468_the-international-orofacial-pain- classification-committee-icop-1-beta-for-review.pdf. Accessed 27 July 2020.

12. Pfau DB, Rolke R, Nickel R, Treede RD, Daublaender M. Somatosensory profiles in subgroups of patients with myogenic temporomandibular disorders and Fibromyalgia Syndrome. Pain 2009;147:72–83.

13. Rolke R, Baron R, Maier C, et al. Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): Standardized protocol and reference values. Pain 2006;123:231–243.

14. Vollert J, Attal N, Baron R, et al. Quantitative sensory testing using DFNS protocol in Europe: An evaluation of heterogeneity across multiple centers in patients with peripheral neuropathic pain and healthy subjects. Pain 2016;157:750–758.

15. Svensson P, Baad-Hansen L, Pigg M, et al. Guidelines and recommendations for assessment of somatosensory function in orofacial pain conditions—A taskforce report. J Oral Rehabil 2011;38:366–394.